Delivery Order SPE2DB22D3301-SPE2DB25FY7NC

Award Date 7/8/25
Potential Completion Date 7/9/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,683.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Vimpat 10 mg/ml solution, a specialty medication used for the treatment of partial-onset seizures. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,805.53 firm fixed-price contract is for the supply of Vimpat 10 mg/ml solution in 200 ml containers. The order has a completion date of May 8, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. The $1,328.28 contract is for the supply of Vimpat 10 mg/ml solution in 200 ml bottles. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp as a single awardee, with a potential value up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,179.55 firm fixed price contract is for the delivery of Vimpat 100 mg tablets. No set-aside requirement was specified. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of Vimpat 10 mg/ml solution in 200 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $1,688.80, was awarded to the prime contractor Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
This federal contract award is a delivery order with a ceiling value of $3,734.94, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The order is for Vimpat 10 mg/ml solution, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 15, 2023. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of Vimpat 10 mg/ml solution in 200 ml bottles, with a ceiling value of $2,026.56 and an ultimate completion date of January 20, 2022. The contract is a firm fixed-price delivery order and was awarded on January 19, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, valued at $1,281.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of VIMPAT 10 MG/ML SOLUTION 200ML, with a performance period ending on April 21, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,840.98, is for the supply of Vimpat 100 mg tablets to support military healthcare programs. It is a firm fixed-price contract with a period of performance through February 2024. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $1,225.01 firm fixed price delivery order is for the supply of Vimpat 10 mg/ml solution, a pharmaceutical product. No set-aside designation was used for this award. The contract is a task order placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY7NC
    Delivery Order

This is a $1,293.61 Firm Fixed Price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Vimpat 10 mg/ml solution, a neurological medication.

The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of medical products and supplies to military healthcare programs through December 2026. This delivery order supports the broader IDC contract.

Generated 10/7/25, 9:52 AM